Cited by 210Glioma Diagnosis and TreatmentCancer, Hypoxia, and MetabolismAcute Myeloid Leukemia Research

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Lactate dehydrogenase A silencing in IDH mutant gliomas

Open access

Chesnelong, Charles, Chaumeil, Myriam M., Blough, Michael D., Al-Najjar, Mohammad, Stechishin, Owen D., Chan, Jennifer A., Pieper, Russell O., Ronen, Sabrina M., Weiss, Samuel, Luchman, H. Artee, Cairncross, J. Gregory·2014·Neuro-Oncology

DOI 10.1093/neuonc/not243PMC PMC3984548

Open this paper in CoChat — free account

Abstract

BACKGROUND: Mutations of the isocitrate dehydrogenase 1 and 2 gene (IDH1/2) were initially thought to enhance cancer cell survival and proliferation by promoting the Warburg effect. However, recent experimental data have shown that production of 2-hydroxyglutarate by IDH mutant cells promotes hypoxia-inducible factor (HIF)1α degradation and, by doing so, may have unexpected metabolic effects. METHODS: We used human glioma tissues and derived brain tumor stem cells (BTSCs) to study the expression of HIF1α target genes in IDH mutant ((mt)) and IDH wild-type ((wt)) tumors. Focusing thereafter on the major glycolytic enzyme, lactate dehydrogenase A (LDHA), we used standard molecular methods and pyrosequencing-based DNA methylation analysis to identify mechanisms by which LDHA expression was regulated in human gliomas. RESULTS: We found that HIF1α-responsive genes, including many essential for glycolysis (SLC2A1, PDK1, LDHA, SLC16A3), were underexpressed in IDH(mt) gliomas and/or derived BTSCs. We then demonstrated that LDHA was silenced in IDH(mt) derived BTSCs, including those that did not retain the mutant IDH1 allele (mIDH(wt)), matched BTSC xenografts, and parental glioma tissues. Silencing of LDHA was associated with increased methylation of the LDHA promoter, as was ectopic expression of mutant IDH1 in immortalized human astrocytes. Furthermore, in a search of The Cancer Genome Atlas, we found low expression and high methylation of LDHA in IDH(mt) glioblastomas. CONCLUSION: To our knowledge, this is the first demonstration of downregulation of LDHA in cancer. Although unexpected findings, silencing of LDHA and downregulation of several other glycolysis essential genes raise the intriguing possibility that IDH(mt) gliomas have limited glycolytic capacity, which may contribute to their slow growth and better prognosis.

Integrity signals

Registry

Crossref · 10.1093/neuonc/not243

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,892
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528

Show all 39 references

Sorted by citations

Items 101–200 of 210

MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy
Najac, C., & Ronen, S. M. (2016) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000104 · Cited by 27
Self-citation
A Comprehensive Review of miRNAs and Their Epigenetic Effects in Glioblastoma
Hasan, H., Afzal, M., Castresana, J. S., & Shahi, M. H. (2023) · Cells · doi:10.3390/cells12121578 · Cited by 28
Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity
Cai, M., Zhao, J., Ding, Q., & Wei, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24454 · Cited by 30
Oxidative and Glycolytic Metabolism: Their Reciprocal Regulation and Dysregulation in Cancer
Cordani, M., Rumio, C., Bontempi, G., Strippoli, R., & Marcucci, F. (2025) · Cells · doi:10.3390/cells14151177 · Cited by 28
Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment
Subramani, E., Radoul, M., Najac, C., Batsios, G., Molloy, A. R., Hong, D., Gillespie, A. M., Santos, R. D., Viswanath, P., Costello, J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1314 · Cited by 25
Self-citation
Cancer metabolism in a snapshot: MRS(I)
Julià‐Sapé, M., Candiota, A. P., & Arús, C. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4054 · Cited by 25
Extracellular glutamate and IDH1R132H inhibitor promote glioma growth by boosting redox potential
Tiburcio, P. D. B., Gillespie, D. L., Jensen, R. L., & Huang, E. L. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03359-w · Cited by 25
Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers
Leca, J., Fortin, J., & Mak, T. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.11.013 · Cited by 23
Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
Auezova, R., Ivanova, N. E., Akshulakov, S., Жетписбаев, Б. Б., Kozhakhmetova, A., Ryskeldiyev, N., Mustafin, K., Teltayev, D., & Auezova, L. (2019) · Cancer Management and Research · doi:10.2147/cmar.s195754 · Cited by 22
Amino Acid and Glucose Fermentation Maintain ATP Content in Mouse and Human Malignant Glioma Cells
Lee, D. C., Ta, N. L., Mukherjee, P., Duraj, T., Domin, M. A., Greenwood, B. P., Karmacharya, S., Narain, N. R., Kiebish, M. A., Chinopoulos, C., et al. (2024) · ASN NEURO · doi:10.1080/17590914.2024.2422268 · Cited by 21
Genetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas
Maeda, M., Ko, M. K., Mane, M. M., Cohen, I., Shindo, M., Vemuri, K., Serganova, I. S., & Blasberg, R. G. (2022) · Cancers · doi:10.3390/cancers14092306 · Cited by 21
Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma
Clark, P. M., Mai, W. X., Cloughesy, T. F., & Nathanson, D. A. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0613-6 · Cited by 21
Metabolic dysregulation of tricarboxylic acid cycle and oxidative phosphorylation in glioblastoma
Trejo‐Solís, C., Serrano-García, N., Castillo‐Rodríguez, R. A., Robledo‐Cadena, D. X., Jiménez‐Farfán, D., Marín‐Hernández, Á., Silva‐Adaya, D., Rodríguez-Pérez, C. E., & Gallardo‐Pérez, J. C. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0054 · Cited by 20
Lower Lactate Levels and Lower Intracellular pH in Patients with IDH -Mutant versus Wild-Type Gliomas
Wenger, K. J., Steinbach, J. P., Bähr, O., Pilatus, U., & Hattingen, E. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6633 · Cited by 20
Long non-coding RNA LINK-A promotes glioma cell growth and invasion via lactate dehydrogenase A
Wu, D., Zhao, B., Cao, X., & Wan, J. (2017) · Oncology Reports · doi:10.3892/or.2017.5806 · Cited by 20
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells
Liu, Y., Gilbert, M. R., Kyprianou, N., Rangnekar, V. M., & Horbinski, C. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1334-7 · Cited by 20
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma
Minami, N., Hong, D., Stevers, N. O., Barger, C. J., Radoul, M., Hong, C., Chen, L., Kim, Y., Batsios, G., Gillespie, A. M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac112 · Cited by 19
Self-citation
Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells
Majerčíková, Z., Dibdiaková, K., Gala, M., Horváth, D., Murín, R., Žoldák, G., & Hatok, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810883 · Cited by 19
U3 snoRNA ‐mediated degradation of ZBTB7A regulates aerobic glycolysis in isocitrate dehydrogenase 1 wild‐type glioblastoma cells
Dong, W., Liu, Y., Wang, P., Ruan, X., Liu, L., Xue, Y., Ma, T., Tiange, E., Wang, D., Yang, C., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14218 · Cited by 17
A Preliminary Study Indicating Improvement in the Median Survival Time of Glioblastoma Multiforme Patients by the Application of Deuterium Depletion in Combination with Conventional Therapy
Somlyai, G., Kovács, B. Z., Papp, A., & Somlyai, I. (2023) · Biomedicines · doi:10.3390/biomedicines11071989 · Cited by 17
Metabolomic comparison between cells over‐expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism
Wen, H., Cho, H. R., Yun, T., Kim, H., Park, C., Lee, S., Choi, S. H., & Park, S. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12950 · Cited by 20
Therapeutic targeting of chromatin alterations in leukemia and solid tumors
Perner, F., Berg, T., Sasca, D., Mersiowsky, S., Gadrey, J. Y., Thomas, J. M., Kühn, M. W. M., & Lübbert, M. (2025) · International Journal of Cancer · doi:10.1002/ijc.35389 · Cited by 16
Polyunsaturated fatty acid-containing phosphatidic acids selectively interact with L-lactate dehydrogenase A and induce its secondary structural change and inactivation
Hoshino, F., & Sakane, F. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158768 · Cited by 15
Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas
Romanidou, O., Kotoula, V., & Fountzilas, G. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20101 · Cited by 15
Metabolic Landscape of a Genetically Engineered Mouse Model of IDH1 Mutant Glioma
Ruiz‐Rodado, V., Seki, T., Dowdy, T., Lita, A., Zhang, M., Han, S., Yang, C., Cherukuri, M. K., Gilbert, M. R., & Larion, M. (2020) · Cancers · doi:10.3390/cancers12061633 · Cited by 15
Microbial metabolites in tumor epigenetic regulation
Zhang, W., Zhang, H., Liao, Y., Jiang, S., Zhang, H., Huang, C., Song, Z., Zhao, R., Lü, P., Kang, X., et al. (2026) · iMeta · doi:10.1002/imt2.70115 · Cited by 17
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells
Hammon, K., Renner, K., Althammer, M., Voll, F., Babl, N., Decking, S.-M., Siska, P. J., Matos, C., Cárdenas-Conejo, Z. E., Mendes, K., et al. (2024) · Haematologica · doi:10.3324/haematol.2023.283597 · Cited by 16
A negative feedback loop underlies the Warburg effect
Jaiswal, A., & Singh, R. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00377-x · Cited by 13
Functional requirement of a wild-type allele for mutant IDH1 to suppress anchorage-independent growth through redox homeostasis
Tiburcio, P. D. B., Xiao, B., Berg, S., Asper, S., Lyne, S. B., Zhang, Y., Zhu, X., Yan, H., & Huang, L. E. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1800-0 · Cited by 12
Role of Extracellular Vesicles in Glioma Progression: Deciphering Cellular Biological Processes to Clinical Applications
Rana, R., Joon, S., Chauhan, K., Rathi, V., Ganguly, N. K., Kumari, C., & Yadav, D. K. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666201207100139 · Cited by 13
Metabolism: an important player in glioma survival and development
Wang, N., Yuan, Y., Hu, T., Xu, H., & Piao, H. (2024) · Discover Oncology · doi:10.1007/s12672-024-01402-5 · Cited by 11
Linking epigenetic signature and metabolic phenotype in IDH mutant and IDH wildtype diffuse glioma
Braun, Y., Filipski, K., Bernatz, S., Baumgarten, P., Roller, B., Zinke, J., Zeiner, P. S., Ilina, E. I., Senft, C., Ronellenfitsch, M. W., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12669 · Cited by 11
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
Cho, N. S., Hagiwara, A., Eldred, B. S. C., Raymond, C., Wang, C., Sanvito, F., Lai, A., Nghiemphu, P. L., Salamon, N., Steelman, L., et al. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac124 · Cited by 11
Nano-Based Technology in Glioblastoma
Bartusik‐Aebisher, D., Rudy, I., Pięta, K., & Aebisher, D. (2025) · Molecules · doi:10.3390/molecules30173485 · Cited by 11
Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study
Yao, J., Hagiwara, A., Oughourlian, T. C., Wang, C., Raymond, C., Pope, W. B., Salamon, N., Lai, A., Ji, M., Nghiemphu, P. L., et al. (2022) · Cancers · doi:10.3390/cancers14102520 · Cited by 10
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Wang, K., Li, Y., Cheng, H., Li, S., Xiang, W., Ming, Y., Chen, L., & Zhou, J. R. (2021) · BMC Neurology · doi:10.1186/s12883-021-02490-4 · Cited by 10
Beyond Isocitrate Dehydrogenase Mutations: Emerging Mechanisms for the Accumulation of the Oncometabolite 2-Hydroxyglutarate
Peng, S., Chen, H., Chen, L., Yang, G., Liu, J., Cheng, X., & Tang, Y. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00254 · Cited by 10
A patient-derived cell model for malignant transformation in IDH-mutant glioma
Kim, O., Sergi, Z., Yu, G., Yamamoto, K., Quezado, M., Abdullaev, Z., Crooks, D., Kishimoto, S., Li, Q., Lu, P., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01860-6 · Cited by 10
Mechanism analysis and targeted therapy of IDH gene mutation in glioma
Ma, X. (2025) · American Journal of Cancer Research · doi:10.62347/nsxc2205 · Cited by 10
IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment
Tiburcio, P. D. B., Xiao, B., Chai, Y., Asper, S., Tripp, S. R., Gillespie, D. L., Jensen, R. L., & Huang, E. L. (2018) · Oncotarget · doi:10.18632/oncotarget.26203 · Cited by 9
Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology
Tsitlakidis, A., Tsingotjidou, A., Κritis, A., Cheva, A., Selviaridis, P., Aifantis, E. C., & Foroglou, N. (2021) · Cancers · doi:10.3390/cancers13184539 · Cited by 9
“Aerobic glycolytic imaging” of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging
Hagiwara, A., Yao, J., Raymond, C., Cho, N. S., Everson, R. G., Patel, K. S., Morrow, D., Desousa, B. R., Mareninov, S., Chun, S., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102882 · Cited by 9
C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors
Viswanath, P., Li, Y., & Ronen, S. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-27359-0_12 · Cited by 8
Self-citation
On an optimal control problem describing lactate production inhibition
Alsayed, H., Fakih, H., Miranville, A., & Wehbe, A. (2021) · Applicable Analysis · doi:10.1080/00036811.2021.1999418 · Cited by 8
Preclinical modeling of lower-grade gliomas
Tang, L. W., Mallela, A. N., Deng, H., Richardson, T. E., Hervey‐Jumper, S. L., McBrayer, S. K., & Abdullah, K. G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1139383 · Cited by 8
Generation of induced neural stem cells with inducible IDH1R132H for analysis of glioma development and drug testing
Rosiak, K., Grot, D., & Rieske, P. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239325 · Cited by 6
IDH-Mutant Gliomas
Tateishi, K., & Yamamoto, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84543 · Cited by 7
Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
Cai, X., Chen, Z., Huang, C., Shen, J., Zeng, W., Feng, S., Liu, Y. S., Li, S., & Chen, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.950917 · Cited by 7
Mogroside V restores glycolytic function via LDHA promoter demethylation independent of alternative splicing in PCOS granulosa cells
Li, S., Wu, J., Lu, R., Zhou, B., Dai, H., Zhang, Z., Yang, X., & Liang, X. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106839 · Cited by 6
LDH-A—Modulation and the Variability of LDH Isoenzyme Profiles in Murine Gliomas: A Link with Metabolic and Growth Responses
Shindo, M., Maeda, M., Ko, M. K., Mane, M. M., Cohen, I., Vemuri, K., Albeg, A. S., Serganova, I. S., & Blasberg, R. G. (2022) · Cancers · doi:10.3390/cancers14092303 · Cited by 6
Novel Post-Translational Modifications and Molecular Substrates in Glioma Identified by Bioinformatics
Balaya, R. D. A., Kumar, S. T. A., Rai, A. B., Kotimoole, C. N., Modi, P. K., & Prasad, T. S. K. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0050 · Cited by 4
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis
Klement, R. J., Popp, I., Kaul, D., Ehret, F., Grosu, A., Polat, B., Sweeney, R. A., & Lewitzki, V. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03926-0 · Cited by 3
Relationship of Carbohydrate Metabolism and Molecular Genetic Markers in Gliomas with Different Degree of Anaplasia
Obukhova, L. M., Nikiforova, О. N., Копытова, Т. В., Orlinskaya, N. Y., Kontorshchikov, М. М., Конторщикова, К. Н., Medyanik, I. A., Grishin, A., & Vasina, D. D. (2021) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-021-05332-y · Cited by 3
Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy
Yang, G., Shan, D., Zhao, R., & Li, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902298 · Cited by 4
Orthogonal targeting of KDM6A/B and HDACs mediates potent therapeutic effects in IDH1 -mutant gliomaPreprint
Kayabölen, A., Yilmaz, E., Şahin, G. N., Seker-Polat, F., Cingöz, A., Isik, B., Acar, S., Wakimoto, H., Cahill, D. P., Solaroğlu, İ., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.26.400234 · Cited by 5
Quantitative susceptibility mapping for the comprehensive assessment of adult-type diffuse gliomas
Shen, P., Li, Y., Xu, W., Zhang, Z., Wang, X., Yang, G., Du, J., Zhang, H., & Tan, Y. Q. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112595 · Cited by 2
Dynamic modelling predicts lactate and IL-1β as interventional targets in metabolic-inflammation-clock regulatory loop in glioma
Sharma, S., Gowda, P., Lathoria, K., Mitra, M. K., & Sen, E. (2023) · Integrative Biology · doi:10.1093/intbio/zyad008 · Cited by 2
Specific expression of lactate dehydrogenases in glioblastoma controls intercellular lactate transfer to promote tumor growth and invasionPreprint
Guyon, J., Fernández‐Moncada, I., Larrieu, C. M., Bouchez, C. L., Chouleur, T., Espedal, H., Røsland, G. V., Daher, B., Barré, A., Dartigues, B., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-690811/v1 · Cited by 2
Oncometabolite-driven enhancer hypermethylation promotes a hyporesponsive microglial state in IDH-mutant gliomasPreprint
Laurenge, A., Pugliese, P., Scuderi, S., Mathon, B., Drouiche, L., Richard, Q., Jouannet, S., Benmohamed, C., Smirnov, K., Sakr, L. H. D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.23.608811 · Cited by 2
On an Optimal Control Problem Describing Lactate Transport Inhibition
Alsayed, H., Fakih, H., Miranville, A., & Wehbe, A. (2023) · Journal of Optimization Theory and Applications · doi:10.1007/s10957-023-02271-8 · Cited by 1
A bacterial enzyme may correct 2-HG accumulation in human cancers
Yin, W. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1235191 · Cited by 1
Nuclear-localized metabolic enzymes: emerging key players in tumor epigenetic regulation
Chen, L., Zhi-hui, W., Yuan, W., Chen, N., Lin, P., Liao, S., & Xie, G. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05316-w · Cited by 1
The evaluation value of multiparametric imaging technology (MULTIPLEX) for grading and molecular subtyping of diffuse glioma patients
Lin, D., Xu, G., He, H., Lin, H., Chen, S., Deng, A., Lv, X., Su, H., & Lv, Y. (2026) · Clinical Radiology · doi:10.1016/j.crad.2026.107265 · Cited by 1
Integrative Analysis of Cytotoxic Lymphocytes‐Mediated Tumour Killing Related Genes Reveals LDHA as a Novel Glioblastoma Therapeutic Target
Yu, S., Li, X., Wu, J., Wang, M., Gong, Z., Zhang, B., Shi, H., Wang, X., & Xiang, W. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71054 · Cited by 1
IDH enzyme inhibition in cancer therapy: mechanisms, mutational insights, and effects of IDH inhibitors in glioma, acute myeloid leukemia and chondrosarcoma
Josephine, A., Kumar, S. A., Varalakshmi, S., & Rajendran, P. (2026) · 3 Biotech · doi:10.1007/s13205-026-04753-8 · Cited by 1
Metabolic Landscape and Emerging Therapeutic Potential in Pediatric and Adult Gliomas
Brock, C. S., Nguyen, L., Pattillo, C., Ahamed, C., Sato, K., & Kumar, K. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062720 · Cited by 1
1p/19q codeletion induces targetable and imageable vulnerabilities in glucose metabolism in oligodendrogliomas
Udutha, S., Batsios, G., Taglang, C., Gillespie, A. M., & Viswanath, P. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag063 · Cited by 1
Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives
Huang, J. Z., Yang, X., Li, F., Li, X., Wei, H., & Li, M. Q. (2026) · Cells · doi:10.3390/cells15121107 · Cited by 1
LDHA deregulation in glioma
LaFlamme, B. A. (2014) · Nature Genetics · doi:10.1038/ng.3024 · Cited by 1
Isocitrate Dehydrogenase (IDH) Mutation in Gliomas
Chesnelong, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-15811-2_25 · Cited by 1
Self-citation
MRS for D-2HG Detection in IDH-Mutant Glioma
Andronesi, O. C., Batchelor, T. T., & Cahill, D. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-27359-0_11 · Cited by 1
MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma
Alfardus, H., McIntyre, A., & Smith, S. J. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pabs.1.2020.7 · Cited by 1
IDH1R132H Mutation Inhibits the Proliferation and Glycolysis of Glioma Cells by Regulating the HIF-1α/LDHA PathwayPreprint
Li, H., Wang, S., & Wang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-299422/v1 · Cited by 1
Hypoxia and Associated Acidosis Generate Cell-Type Specific Myeloid Responses in GlioblastomaPreprint
Tiihonen, A. M., Salonen, I., Koivisto, I., Ritamäki, A. S., Jaatinen, S., Hyvärinen, T., Tilvis, J., Kreutzer, J., Karabiyik, G., Mäntylä, S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.707379 · Cited by 1
Expressão gênica da família das lisil oxidases e papel funcional de LOX em astrocitomas
da Silva, R. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-12012015-091413
The Implication of Antiangiogenic Treatment of Malignancies on Human Metabolism
Obad, N., & Bjerkvig, R. (2017) · Springer eBooks · doi:10.1007/978-3-319-31215-6_35-1
Targeted RNA NextGenSeq profiling in oncology using single molecule molecular inversion probesPreprint
Lenting, K., van den Heuvel, C. N. A. M., van Ewijk, A., Tindall, E. A., Ge, W., Küsters, B., Dorsthorst, M. T., ter Laan, M., Huynen, M. A., & Leenders, W. P. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/440065
Impact of San-mediated Signaling on Glioblastoma and Neuroblastoma Metabolism
Silva, M. R. (2018) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc006885
Integration into cancer studies
Viswanath, P. (2021) · Advances in magnetic resonance technology and applications · doi:10.1016/b978-0-12-822269-0.00010-5
Tecnologia de fabricação de malte: uma revisão
Porto, P. D. D. (2011)
The Implication of Anti-angiogenic Treatment of Malignancies on Human Metabolism
Obad, N., & Bjerkvig, R. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_35
Development of Hyperpolarized MR Imaging for Clinical Application
Matsuo, M., & Hyodo, F. (2022) · Japanese Journal of Magnetic Resonance in Medicine · doi:10.2463/jjmrm.2022-1767
BCL6 is a context-dependent mediator of the glioblastoma therapy response
Tribe, A. K. W. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.21937850
A negative feedback loop underlies the Warburg effectPreprint
Singh, R., & Jaiswal, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3465493/v1
On a singular mathematical model for brain lactate kinetics
Ali, N., Fakih, H., & Wehbe, A. (2024) · Mathematical Methods in the Applied Sciences · doi:10.1002/mma.9898
Differences in advanced radiologic features of glioma subtypes under the 2021 WHO classification of tumors of the central Nervous system
Kumarapuram, S., Strotzer, Q., Rapalino, O., & Gupta, R. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112474
Additional file 1 of GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP/PKA/CREB pathway to promote glioma progression
Yan, C., Yang, Z., Chen, P., Yeh, Y., Sun, C., Xie, T., Huang, W., & Zhang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26701963
Additional file 1 of Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Wang, K., Li, Y., Cheng, H., Li, S., Xiang, W., Ming, Y., Chen, L., & Zhou, J. (2021) · Figshare · doi:10.6084/m9.figshare.17073273
Additional file 3 of Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Wang, K., Li, Y., Cheng, H., Li, S., Xiang, W., Ming, Y., Chen, L., & Zhou, J. (2021) · Figshare · doi:10.6084/m9.figshare.17073279
Additional file 2 of A patient-derived cell model for malignant transformation in IDH-mutant glioma
Kim, O., Sergi, Z., Yu, G., Yamamoto, K., Quezado, M., Abdullaev, Z., Crooks, D. R., Kishimoto, S., Li, Q., Lu, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981907
Additional file 1 of A patient-derived cell model for malignant transformation in IDH-mutant glioma
Kim, O., Sergi, Z., Yu, G., Yamamoto, K., Quezado, M., Abdullaev, Z., Crooks, D. R., Kishimoto, S., Li, Q., Lu, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981901
Additional file 11 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111140
Additional file 7 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111167
Additional file 6 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111164
Additional file 13 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111146
Additional file 2 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111152
Additional file 12 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111143
Additional file 2 of Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
Wang, K., Li, Y., Cheng, H., Li, S., Xiang, W., Ming, Y., Chen, L., & Zhou, J. (2021) · Figshare · doi:10.6084/m9.figshare.17073276
Additional file 10 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111137
Additional file 9 of Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
Ho, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111173

Authors: Chesnelong, C., Chaumeil, M. M., Blough, M. D., Al-Najjar, M., Stechishin, O. D., Chan, J. A., Pieper, R. O., Ronen, S. M., Weiss, S., Luchman, H. A., & Cairncross, J. G.
Affiliations: Foothills Medical Centre (CA)
Corresponding author: Cairncross, J. Gregory
ORCID: Chaumeil, Myriam M.
Blough, Michael D.
Chan, Jennifer A.
Weiss, Samuel
Luchman, H. Artee
Cairncross, J. Gregory
Venue: Neuro-Oncology
Publisher: Oxford University Press (OUP)
Published: 2013-12-22
Volume: 16
Issue: 5
Pages: 686-695
ISSN: 1522-8517 (ISSN-L)
1523-5866
DOI: 10.1093/neuonc/not243
PMC: PMC3984548
OpenAlex: W2101246344
Cited by: 210
References: 39
Citations by year: 2026: 16 · 2025: 10 · 2024: 16 · 2023: 13 · 2022: 19 · 2021: 33 · 2020: 22 · 2019: 16 · 2018: 20 · 2017: 12 · 2016: 9 · 2015: 12 · 2014: 11
FWCI: 5.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Neuro-Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Cancer Institute (R01CA172845)
Topics: Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: LDHA, IDH mutation, isocitrate dehydrogenase, glioma, brain tumor stem cells, hypoxia-inducible factor-1α, 2-hydroxyglutarate, DNA methylation, promoter methylation, glycolysis, glioblastoma, Warburg effect, cancer metabolism
MeSH terms: Lactate Dehydrogenase 5, Animals, Glioblastoma, Glioma, Humans, Isocitrate Dehydrogenase, Isoenzymes, L-Lactate Dehydrogenase, Mutation, Gene Expression Regulation, Neoplastic, DNA Methylation, Brain Stem Neoplasms, Gene Silencing, Cell Line, Tumor, Mice, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lactate dehydrogenase A silencing in IDH mutant gliomas

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks